The quantification of a panel of antiepileptic drugs in human plasma has been implemented and analytically validated on a TSQ Quantum Access MAX mass spectrometer using the MassTox TDM Series A kit for antiepileptics from Chromsystems. The TSQ Quantum Access MAX mass spectrometer proved to have the proper sensitivity, accuracy, and precision for the application of this analytical method to clinical research.